ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plasmid Manufacture Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-15Q14479
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Plasmid Manufacture Market Research Report 2023
BUY CHAPTERS

Global Plasmid Manufacture Market Research Report 2024

Code: QYRE-Auto-15Q14479
Report
June 2024
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher Scientific
Catalent
The Discovery Labs
BioCentriq
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith Co., Ltd.
Thermogenesis
Anemocyte Srl
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions
Aldevron
Lonza
Charles River

Plasmid Manufacture Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Plasmid Manufacture Market

Plasmid Manufacture Market

The global Plasmid Manufacture market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Plasmid Manufacture, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid Manufacture.

Report Scope

The Plasmid Manufacture market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plasmid Manufacture market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid Manufacture companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Plasmid Manufacture Market Report

Report Metric Details
Report Name Plasmid Manufacture Market
CAGR 5%
Segment by Type
  • Preclinical Plasmid
  • Clinical Plasmid
  • Commercial Plasmid
Segment by Application
  • Commercial
  • Academic Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, Lonza, Aldevron, Thermo Fisher Scientific, Catalent, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO, Cell Therapies, AGC Biologics, Cytiva, Helixmith, ThermoGenesis, Anemocyte, CBM, Bio Elpida, Genezen, CCRM, RoslinCT, GenScript ProBio, Oxford BioMedica, Porton Pharma Solutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Plasmid Manufacture companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Plasmid Manufacture Market report?

Ans: The main players in the Plasmid Manufacture Market are Charles River, Lonza, Aldevron, Thermo Fisher Scientific, Catalent, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies, Exothera, WuXi AppTec, Pharmaron, OBiO, Cell Therapies, AGC Biologics, Cytiva, Helixmith, ThermoGenesis, Anemocyte, CBM, Bio Elpida, Genezen, CCRM, RoslinCT, GenScript ProBio, Oxford BioMedica, Porton Pharma Solutions

What are the Application segmentation covered in the Plasmid Manufacture Market report?

Ans: The Applications covered in the Plasmid Manufacture Market report are Commercial, Academic Research, Others

What are the Type segmentation covered in the Plasmid Manufacture Market report?

Ans: The Types covered in the Plasmid Manufacture Market report are Preclinical Plasmid, Clinical Plasmid, Commercial Plasmid

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid Manufacture Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Preclinical Plasmid
1.2.3 Clinical Plasmid
1.2.4 Commercial Plasmid
1.3 Market by Application
1.3.1 Global Plasmid Manufacture Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid Manufacture Market Perspective (2019-2030)
2.2 Plasmid Manufacture Growth Trends by Region
2.2.1 Global Plasmid Manufacture Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Plasmid Manufacture Historic Market Size by Region (2019-2024)
2.2.3 Plasmid Manufacture Forecasted Market Size by Region (2025-2030)
2.3 Plasmid Manufacture Market Dynamics
2.3.1 Plasmid Manufacture Industry Trends
2.3.2 Plasmid Manufacture Market Drivers
2.3.3 Plasmid Manufacture Market Challenges
2.3.4 Plasmid Manufacture Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid Manufacture Players by Revenue
3.1.1 Global Top Plasmid Manufacture Players by Revenue (2019-2024)
3.1.2 Global Plasmid Manufacture Revenue Market Share by Players (2019-2024)
3.2 Global Plasmid Manufacture Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid Manufacture Revenue
3.4 Global Plasmid Manufacture Market Concentration Ratio
3.4.1 Global Plasmid Manufacture Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid Manufacture Revenue in 2023
3.5 Plasmid Manufacture Key Players Head office and Area Served
3.6 Key Players Plasmid Manufacture Product Solution and Service
3.7 Date of Enter into Plasmid Manufacture Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid Manufacture Breakdown Data by Type
4.1 Global Plasmid Manufacture Historic Market Size by Type (2019-2024)
4.2 Global Plasmid Manufacture Forecasted Market Size by Type (2025-2030)
5 Plasmid Manufacture Breakdown Data by Application
5.1 Global Plasmid Manufacture Historic Market Size by Application (2019-2024)
5.2 Global Plasmid Manufacture Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Plasmid Manufacture Market Size (2019-2030)
6.2 North America Plasmid Manufacture Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Plasmid Manufacture Market Size by Country (2019-2024)
6.4 North America Plasmid Manufacture Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid Manufacture Market Size (2019-2030)
7.2 Europe Plasmid Manufacture Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Plasmid Manufacture Market Size by Country (2019-2024)
7.4 Europe Plasmid Manufacture Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid Manufacture Market Size (2019-2030)
8.2 Asia-Pacific Plasmid Manufacture Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Plasmid Manufacture Market Size by Region (2019-2024)
8.4 Asia-Pacific Plasmid Manufacture Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid Manufacture Market Size (2019-2030)
9.2 Latin America Plasmid Manufacture Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Plasmid Manufacture Market Size by Country (2019-2024)
9.4 Latin America Plasmid Manufacture Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid Manufacture Market Size (2019-2030)
10.2 Middle East & Africa Plasmid Manufacture Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Plasmid Manufacture Market Size by Country (2019-2024)
10.4 Middle East & Africa Plasmid Manufacture Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River Plasmid Manufacture Introduction
11.1.4 Charles River Revenue in Plasmid Manufacture Business (2019-2024)
11.1.5 Charles River Recent Development
11.2 Lonza
11.2.1 Lonza Company Detail
11.2.2 Lonza Business Overview
11.2.3 Lonza Plasmid Manufacture Introduction
11.2.4 Lonza Revenue in Plasmid Manufacture Business (2019-2024)
11.2.5 Lonza Recent Development
11.3 Aldevron
11.3.1 Aldevron Company Detail
11.3.2 Aldevron Business Overview
11.3.3 Aldevron Plasmid Manufacture Introduction
11.3.4 Aldevron Revenue in Plasmid Manufacture Business (2019-2024)
11.3.5 Aldevron Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Plasmid Manufacture Introduction
11.4.4 Thermo Fisher Scientific Revenue in Plasmid Manufacture Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Catalent
11.5.1 Catalent Company Detail
11.5.2 Catalent Business Overview
11.5.3 Catalent Plasmid Manufacture Introduction
11.5.4 Catalent Revenue in Plasmid Manufacture Business (2019-2024)
11.5.5 Catalent Recent Development
11.6 The Discovery Labs
11.6.1 The Discovery Labs Company Detail
11.6.2 The Discovery Labs Business Overview
11.6.3 The Discovery Labs Plasmid Manufacture Introduction
11.6.4 The Discovery Labs Revenue in Plasmid Manufacture Business (2019-2024)
11.6.5 The Discovery Labs Recent Development
11.7 BIOCENTRIQ
11.7.1 BIOCENTRIQ Company Detail
11.7.2 BIOCENTRIQ Business Overview
11.7.3 BIOCENTRIQ Plasmid Manufacture Introduction
11.7.4 BIOCENTRIQ Revenue in Plasmid Manufacture Business (2019-2024)
11.7.5 BIOCENTRIQ Recent Development
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.8.3 FUJIFILM Diosynth Biotechnologies Plasmid Manufacture Introduction
11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Plasmid Manufacture Business (2019-2024)
11.8.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.9 Exothera
11.9.1 Exothera Company Detail
11.9.2 Exothera Business Overview
11.9.3 Exothera Plasmid Manufacture Introduction
11.9.4 Exothera Revenue in Plasmid Manufacture Business (2019-2024)
11.9.5 Exothera Recent Development
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Detail
11.10.2 WuXi AppTec Business Overview
11.10.3 WuXi AppTec Plasmid Manufacture Introduction
11.10.4 WuXi AppTec Revenue in Plasmid Manufacture Business (2019-2024)
11.10.5 WuXi AppTec Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Detail
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron Plasmid Manufacture Introduction
11.11.4 Pharmaron Revenue in Plasmid Manufacture Business (2019-2024)
11.11.5 Pharmaron Recent Development
11.12 OBiO
11.12.1 OBiO Company Detail
11.12.2 OBiO Business Overview
11.12.3 OBiO Plasmid Manufacture Introduction
11.12.4 OBiO Revenue in Plasmid Manufacture Business (2019-2024)
11.12.5 OBiO Recent Development
11.13 Cell Therapies
11.13.1 Cell Therapies Company Detail
11.13.2 Cell Therapies Business Overview
11.13.3 Cell Therapies Plasmid Manufacture Introduction
11.13.4 Cell Therapies Revenue in Plasmid Manufacture Business (2019-2024)
11.13.5 Cell Therapies Recent Development
11.14 AGC Biologics
11.14.1 AGC Biologics Company Detail
11.14.2 AGC Biologics Business Overview
11.14.3 AGC Biologics Plasmid Manufacture Introduction
11.14.4 AGC Biologics Revenue in Plasmid Manufacture Business (2019-2024)
11.14.5 AGC Biologics Recent Development
11.15 Cytiva
11.15.1 Cytiva Company Detail
11.15.2 Cytiva Business Overview
11.15.3 Cytiva Plasmid Manufacture Introduction
11.15.4 Cytiva Revenue in Plasmid Manufacture Business (2019-2024)
11.15.5 Cytiva Recent Development
11.16 Helixmith
11.16.1 Helixmith Company Detail
11.16.2 Helixmith Business Overview
11.16.3 Helixmith Plasmid Manufacture Introduction
11.16.4 Helixmith Revenue in Plasmid Manufacture Business (2019-2024)
11.16.5 Helixmith Recent Development
11.17 ThermoGenesis
11.17.1 ThermoGenesis Company Detail
11.17.2 ThermoGenesis Business Overview
11.17.3 ThermoGenesis Plasmid Manufacture Introduction
11.17.4 ThermoGenesis Revenue in Plasmid Manufacture Business (2019-2024)
11.17.5 ThermoGenesis Recent Development
11.18 Anemocyte
11.18.1 Anemocyte Company Detail
11.18.2 Anemocyte Business Overview
11.18.3 Anemocyte Plasmid Manufacture Introduction
11.18.4 Anemocyte Revenue in Plasmid Manufacture Business (2019-2024)
11.18.5 Anemocyte Recent Development
11.19 CBM
11.19.1 CBM Company Detail
11.19.2 CBM Business Overview
11.19.3 CBM Plasmid Manufacture Introduction
11.19.4 CBM Revenue in Plasmid Manufacture Business (2019-2024)
11.19.5 CBM Recent Development
11.20 Bio Elpida
11.20.1 Bio Elpida Company Detail
11.20.2 Bio Elpida Business Overview
11.20.3 Bio Elpida Plasmid Manufacture Introduction
11.20.4 Bio Elpida Revenue in Plasmid Manufacture Business (2019-2024)
11.20.5 Bio Elpida Recent Development
11.21 Genezen
11.21.1 Genezen Company Detail
11.21.2 Genezen Business Overview
11.21.3 Genezen Plasmid Manufacture Introduction
11.21.4 Genezen Revenue in Plasmid Manufacture Business (2019-2024)
11.21.5 Genezen Recent Development
11.22 CCRM
11.22.1 CCRM Company Detail
11.22.2 CCRM Business Overview
11.22.3 CCRM Plasmid Manufacture Introduction
11.22.4 CCRM Revenue in Plasmid Manufacture Business (2019-2024)
11.22.5 CCRM Recent Development
11.23 RoslinCT
11.23.1 RoslinCT Company Detail
11.23.2 RoslinCT Business Overview
11.23.3 RoslinCT Plasmid Manufacture Introduction
11.23.4 RoslinCT Revenue in Plasmid Manufacture Business (2019-2024)
11.23.5 RoslinCT Recent Development
11.24 GenScript ProBio
11.24.1 GenScript ProBio Company Detail
11.24.2 GenScript ProBio Business Overview
11.24.3 GenScript ProBio Plasmid Manufacture Introduction
11.24.4 GenScript ProBio Revenue in Plasmid Manufacture Business (2019-2024)
11.24.5 GenScript ProBio Recent Development
11.25 Oxford BioMedica
11.25.1 Oxford BioMedica Company Detail
11.25.2 Oxford BioMedica Business Overview
11.25.3 Oxford BioMedica Plasmid Manufacture Introduction
11.25.4 Oxford BioMedica Revenue in Plasmid Manufacture Business (2019-2024)
11.25.5 Oxford BioMedica Recent Development
11.26 Porton Pharma Solutions
11.26.1 Porton Pharma Solutions Company Detail
11.26.2 Porton Pharma Solutions Business Overview
11.26.3 Porton Pharma Solutions Plasmid Manufacture Introduction
11.26.4 Porton Pharma Solutions Revenue in Plasmid Manufacture Business (2019-2024)
11.26.5 Porton Pharma Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Thermo Fisher Scientific
Catalent
The Discovery Labs
BioCentriq
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith Co., Ltd.
Thermogenesis
Anemocyte Srl
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions
Aldevron
Lonza
Charles River
List of Tables
    Table 1. Global Plasmid Manufacture Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Preclinical Plasmid
    Table 3. Key Players of Clinical Plasmid
    Table 4. Key Players of Commercial Plasmid
    Table 5. Global Plasmid Manufacture Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Plasmid Manufacture Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Plasmid Manufacture Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Plasmid Manufacture Market Share by Region (2019-2024)
    Table 9. Global Plasmid Manufacture Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Plasmid Manufacture Market Share by Region (2025-2030)
    Table 11. Plasmid Manufacture Market Trends
    Table 12. Plasmid Manufacture Market Drivers
    Table 13. Plasmid Manufacture Market Challenges
    Table 14. Plasmid Manufacture Market Restraints
    Table 15. Global Plasmid Manufacture Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Plasmid Manufacture Market Share by Players (2019-2024)
    Table 17. Global Top Plasmid Manufacture Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid Manufacture as of 2023)
    Table 18. Ranking of Global Top Plasmid Manufacture Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Plasmid Manufacture Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Plasmid Manufacture Product Solution and Service
    Table 22. Date of Enter into Plasmid Manufacture Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Plasmid Manufacture Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Plasmid Manufacture Revenue Market Share by Type (2019-2024)
    Table 26. Global Plasmid Manufacture Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Plasmid Manufacture Revenue Market Share by Type (2025-2030)
    Table 28. Global Plasmid Manufacture Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Plasmid Manufacture Revenue Market Share by Application (2019-2024)
    Table 30. Global Plasmid Manufacture Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Plasmid Manufacture Revenue Market Share by Application (2025-2030)
    Table 32. North America Plasmid Manufacture Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Plasmid Manufacture Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Plasmid Manufacture Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Plasmid Manufacture Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Plasmid Manufacture Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Plasmid Manufacture Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Plasmid Manufacture Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Plasmid Manufacture Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Plasmid Manufacture Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Plasmid Manufacture Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Plasmid Manufacture Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Plasmid Manufacture Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Plasmid Manufacture Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Plasmid Manufacture Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Plasmid Manufacture Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Charles River Company Detail
    Table 48. Charles River Business Overview
    Table 49. Charles River Plasmid Manufacture Product
    Table 50. Charles River Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 51. Charles River Recent Development
    Table 52. Lonza Company Detail
    Table 53. Lonza Business Overview
    Table 54. Lonza Plasmid Manufacture Product
    Table 55. Lonza Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 56. Lonza Recent Development
    Table 57. Aldevron Company Detail
    Table 58. Aldevron Business Overview
    Table 59. Aldevron Plasmid Manufacture Product
    Table 60. Aldevron Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 61. Aldevron Recent Development
    Table 62. Thermo Fisher Scientific Company Detail
    Table 63. Thermo Fisher Scientific Business Overview
    Table 64. Thermo Fisher Scientific Plasmid Manufacture Product
    Table 65. Thermo Fisher Scientific Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 66. Thermo Fisher Scientific Recent Development
    Table 67. Catalent Company Detail
    Table 68. Catalent Business Overview
    Table 69. Catalent Plasmid Manufacture Product
    Table 70. Catalent Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 71. Catalent Recent Development
    Table 72. The Discovery Labs Company Detail
    Table 73. The Discovery Labs Business Overview
    Table 74. The Discovery Labs Plasmid Manufacture Product
    Table 75. The Discovery Labs Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 76. The Discovery Labs Recent Development
    Table 77. BIOCENTRIQ Company Detail
    Table 78. BIOCENTRIQ Business Overview
    Table 79. BIOCENTRIQ Plasmid Manufacture Product
    Table 80. BIOCENTRIQ Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 81. BIOCENTRIQ Recent Development
    Table 82. FUJIFILM Diosynth Biotechnologies Company Detail
    Table 83. FUJIFILM Diosynth Biotechnologies Business Overview
    Table 84. FUJIFILM Diosynth Biotechnologies Plasmid Manufacture Product
    Table 85. FUJIFILM Diosynth Biotechnologies Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 86. FUJIFILM Diosynth Biotechnologies Recent Development
    Table 87. Exothera Company Detail
    Table 88. Exothera Business Overview
    Table 89. Exothera Plasmid Manufacture Product
    Table 90. Exothera Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 91. Exothera Recent Development
    Table 92. WuXi AppTec Company Detail
    Table 93. WuXi AppTec Business Overview
    Table 94. WuXi AppTec Plasmid Manufacture Product
    Table 95. WuXi AppTec Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 96. WuXi AppTec Recent Development
    Table 97. Pharmaron Company Detail
    Table 98. Pharmaron Business Overview
    Table 99. Pharmaron Plasmid Manufacture Product
    Table 100. Pharmaron Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 101. Pharmaron Recent Development
    Table 102. OBiO Company Detail
    Table 103. OBiO Business Overview
    Table 104. OBiO Plasmid Manufacture Product
    Table 105. OBiO Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 106. OBiO Recent Development
    Table 107. Cell Therapies Company Detail
    Table 108. Cell Therapies Business Overview
    Table 109. Cell Therapies Plasmid Manufacture Product
    Table 110. Cell Therapies Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 111. Cell Therapies Recent Development
    Table 112. AGC Biologics Company Detail
    Table 113. AGC Biologics Business Overview
    Table 114. AGC Biologics Plasmid Manufacture Product
    Table 115. AGC Biologics Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 116. AGC Biologics Recent Development
    Table 117. Cytiva Company Detail
    Table 118. Cytiva Business Overview
    Table 119. Cytiva Plasmid Manufacture Product
    Table 120. Cytiva Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 121. Cytiva Recent Development
    Table 122. Helixmith Company Detail
    Table 123. Helixmith Business Overview
    Table 124. Helixmith Plasmid Manufacture Product
    Table 125. Helixmith Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 126. Helixmith Recent Development
    Table 127. ThermoGenesis Company Detail
    Table 128. ThermoGenesis Business Overview
    Table 129. ThermoGenesis Plasmid Manufacture Product
    Table 130. ThermoGenesis Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 131. ThermoGenesis Recent Development
    Table 132. Anemocyte Company Detail
    Table 133. Anemocyte Business Overview
    Table 134. Anemocyte Plasmid Manufacture Product
    Table 135. Anemocyte Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 136. Anemocyte Recent Development
    Table 137. CBM Company Detail
    Table 138. CBM Business Overview
    Table 139. CBM Plasmid Manufacture Product
    Table 140. CBM Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 141. CBM Recent Development
    Table 142. Bio Elpida Company Detail
    Table 143. Bio Elpida Business Overview
    Table 144. Bio Elpida Plasmid Manufacture Product
    Table 145. Bio Elpida Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 146. Bio Elpida Recent Development
    Table 147. Genezen Company Detail
    Table 148. Genezen Business Overview
    Table 149. Genezen Plasmid Manufacture Product
    Table 150. Genezen Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 151. Genezen Recent Development
    Table 152. CCRM Company Detail
    Table 153. CCRM Business Overview
    Table 154. CCRM Plasmid Manufacture Product
    Table 155. CCRM Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 156. CCRM Recent Development
    Table 157. RoslinCT Company Detail
    Table 158. RoslinCT Business Overview
    Table 159. RoslinCT Plasmid Manufacture Product
    Table 160. RoslinCT Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 161. RoslinCT Recent Development
    Table 162. GenScript ProBio Company Detail
    Table 163. GenScript ProBio Business Overview
    Table 164. GenScript ProBio Plasmid Manufacture Product
    Table 165. GenScript ProBio Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 166. GenScript ProBio Recent Development
    Table 167. Oxford BioMedica Company Detail
    Table 168. Oxford BioMedica Business Overview
    Table 169. Oxford BioMedica Plasmid Manufacture Product
    Table 170. Oxford BioMedica Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 171. Oxford BioMedica Recent Development
    Table 172. Porton Pharma Solutions Company Detail
    Table 173. Porton Pharma Solutions Business Overview
    Table 174. Porton Pharma Solutions Plasmid Manufacture Product
    Table 175. Porton Pharma Solutions Revenue in Plasmid Manufacture Business (2019-2024) & (US$ Million)
    Table 176. Porton Pharma Solutions Recent Development
    Table 177. Research Programs/Design for This Report
    Table 178. Key Data Information from Secondary Sources
    Table 179. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Plasmid Manufacture Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Plasmid Manufacture Market Share by Type: 2023 VS 2030
    Figure 3. Preclinical Plasmid Features
    Figure 4. Clinical Plasmid Features
    Figure 5. Commercial Plasmid Features
    Figure 6. Global Plasmid Manufacture Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Plasmid Manufacture Market Share by Application: 2023 VS 2030
    Figure 8. Commercial Case Studies
    Figure 9. Academic Research Case Studies
    Figure 10. Others Case Studies
    Figure 11. Plasmid Manufacture Report Years Considered
    Figure 12. Global Plasmid Manufacture Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Plasmid Manufacture Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Plasmid Manufacture Market Share by Region: 2023 VS 2030
    Figure 15. Global Plasmid Manufacture Market Share by Players in 2023
    Figure 16. Global Top Plasmid Manufacture Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid Manufacture as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Plasmid Manufacture Revenue in 2023
    Figure 18. North America Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Plasmid Manufacture Market Share by Country (2019-2030)
    Figure 20. United States Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Plasmid Manufacture Market Share by Country (2019-2030)
    Figure 24. Germany Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Plasmid Manufacture Market Share by Region (2019-2030)
    Figure 32. China Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Plasmid Manufacture Market Share by Country (2019-2030)
    Figure 40. Mexico Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Plasmid Manufacture Market Share by Country (2019-2030)
    Figure 44. Turkey Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Plasmid Manufacture Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Charles River Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 47. Lonza Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 48. Aldevron Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 50. Catalent Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 51. The Discovery Labs Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 52. BIOCENTRIQ Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 53. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 54. Exothera Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 55. WuXi AppTec Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 56. Pharmaron Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 57. OBiO Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 58. Cell Therapies Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 59. AGC Biologics Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 60. Cytiva Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 61. Helixmith Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 62. ThermoGenesis Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 63. Anemocyte Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 64. CBM Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 65. Bio Elpida Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 66. Genezen Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 67. CCRM Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 68. RoslinCT Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 69. GenScript ProBio Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 70. Oxford BioMedica Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 71. Porton Pharma Solutions Revenue Growth Rate in Plasmid Manufacture Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions